Sacubitril/Valsartan in Patients with HFrEF Undergoing Maintenance Hemodialysis, Evidence of Cardiac Reverse Remodeling During 12-Month Follow-Up: Case Series
Sonila Mocka, Danilo Baccino, Ledio Shurdi, Stefano Cornara, Stefano Ferraro · 2026
Read Sacubitril/Valsartan in Patients with HFrEF Undergoing Maintenance Hemodialysis, Evidence of Cardiac Reverse Remodeling During 12-Month Follow-Up: Case Series by Sonila Mocka, Danilo Baccino, Ledio Shurdi, Stefano Cornara, Stefano Ferraro (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13611196.txt.
Description
Sonila Mocka and co-authors report four dialysis patients whose weak hearts grew stronger on a drug in this 2026 case series. All four men had heart failure with a reduced pumping fraction and kidneys on maintenance dialysis, a group where the drug sacubitril-valsartan is rarely used for lack of proof.
At the start, their hearts pumped at about a third of the healthy share, and strain markers ran very high. After twelve months on the drug, pumping rose past half, and heart chambers shrank toward normal size. Lung pressure fell and strain markers dropped steeply. No dangerous potassium spikes or dialysis blood pressure crashes occurred. The authors urge a proper trial in this group.
Catalog record
| CREATOR | Sonila Mocka, Danilo Baccino, Ledio Shurdi, Stefano Cornara, Stefano Ferraro |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 22 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |